National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

liothyronine sodium
The sodium salt form of liothyronine, a synthetic form of the levorotatory isomer of the naturally occurring thyroid hormone triiodothyronine (T3). Liothyronine sodium binds to nuclear thyroid receptors which then bind to thyroid hormone response elements of target genes. As a result, liothyronine sodium induces gene expression that is required for normal growth and development. Liothyronine sodium is more potent and has a more rapid action than thyroxine (T4). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Cytomel
Triostat



Previous:Lidothesin, Linfolizin, Linomide, lintuzumab, Lioresal
Next:Lipiodol, Lipitor, Lipo-Lutin, LipoDox, liposomal amphotericin B

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov